United States· US:69945-180_3c4363ac-ad4f-f5fc-e063-6294a90a1ec2
GALLIUM CITRATE GA-67
A medicinal product containing gallium chloride ga-67, registered in United States by Curium US LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- GALLIUM CHLORIDE GA-67
- Manufacturer
- Curium US LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1169945180061 VIAL in 1 CAN (69945-180-06) / 3.3 mL in 1 VIAL
- ndc1169945180121 VIAL in 1 CAN (69945-180-12) / 6.6 mL in 1 VIAL
- ndc1169945-180-06
- ndc1169945-180-12
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/42e49047-109e-4f66-b88f-1405e4838247 GET /v1/drugs/42e49047-109e-4f66-b88f-1405e4838247?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "2",
"substance": "GALLIUM CHLORIDE GA-67",
"productndc": "69945-180",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mCi/mL",
"application_number": "NDA018058",
"marketing_category": "NDA"
}See everything about gallium chloride ga-67.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.